---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-027252"
form_type: "8-K"
ticker: "KYNB"
cik: "0000921299"
company_name: "KYNTRA BIO, INC."
filed_at: "2023-06-09T23:59:59+00:00"
generated_at: "2026-06-14T04:33:25.101474+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# FibroGen shareholders elect Class III directors, approve say-on-pay and auditor ratification

## Summary
- Enrique Conterno, Aoife Brennan, and Gerald Lema elected as Class III directors with 67.4M, 69.2M, and 67.6M votes for, respectively.
- Advisory vote on executive compensation passed: 48.7M for, 21.9M against, 89K abstain (31% opposed).
- Ratification of PricewaterhouseCoopers as auditor for 2023: 78.5M for, 674K against, 2.2M abstain.

## SEC filing metadata
- accession: 0000950170-23-027252
- form_type: 8-K
- ticker: KYNB
- cik: 0000921299
- company_name: KYNTRA BIO, INC.
- filed_at: 2023-06-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/921299/000095017023027252/0000950170-23-027252-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/921299/000095017023027252/fgen-20230607.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-027252
- JSON: https://secwatch.observer/filing/0000950170-23-027252.json
- Plain text: https://secwatch.observer/filing/0000950170-23-027252.txt

## Key facts
- Shareholder Votes
  KYNTRA BIO, INC. shareholders approved Election of Class III directors at the 2023-06-07 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-07
  source text: (i) Enrique Conterno: 67,436,799 shares of Common Stock voted for, 3,332,142 withheld, and 10,632,221 broker non-votes; (ii) Aoife Brennan, M.B., B.Ch.: 69,182,144 shares of Common Stock voted for, 1,586,797 withheld, and 10,632,221 broker non-votes; and (iii) Gerald Lema: 67,636,643 shares of Common Stock voted for, 3,132,298 withheld, and 10,632,221 broker non-votes.
  evidence_url: https://www.sec.gov/Archives/edgar/data/921299/000095017023027252/0000950170-23-027252-index.htm
- Shareholder Votes
  KYNTRA BIO, INC. shareholders approved Advisory vote on executive compensation at the 2023-06-07 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-06-07
  source text: The stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers
  evidence_url: https://www.sec.gov/Archives/edgar/data/921299/000095017023027252/0000950170-23-027252-index.htm
- Shareholder Votes
  KYNTRA BIO, INC. shareholders approved Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for fiscal year 2023 at the 2023-06-07 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-07
  source text: 78,505,537 shares of Common Stock voted for, 674,522 against, and 2,221,103 abstaining.
  evidence_url: https://www.sec.gov/Archives/edgar/data/921299/000095017023027252/0000950170-23-027252-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.